Regeneron Pharmaceuticals Inc
REGNHealthcare|Biotechnology|USA
$763.04
+1.19 (+0.16%)
DCF (FCF)
$641.30
Tangible Book
$283.77
Graham Number
$532.32
Earnings Power
$496.16
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (781)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| RYAN ARTHUR F | Director | 2026-04-01 | SELL | 100 | $777.27 | $77.7K |
| RYAN ARTHUR F | Director | 2026-03-02 | SELL | 100 | $785.5 | $78.6K |
| Zoghbi Huda Y | Director | 2026-02-19 | SELL | 1,638 | $781.33 | $1279.8K |
| RYAN ARTHUR F | Director | 2026-02-09 | SELL | 100 | $778.53 | $77.9K |
| Pitofsky Jason | SVP Controller | 2026-02-09 | SELL | 2,036 | $778.52 | $1585.1K |
| Bassler Bonnie L | Director | 2026-01-07 | SELL | 1,500 | $800 | $1200K |
| Bassler Bonnie L | Director | 2025-11-20 | SELL | 760 | $750 | $570K |
| Pitofsky Jason | VP Controller | 2025-11-07 | SELL | 431 | $651.43 | $280.8K |
| POON CHRISTINE A | Director | 2025-10-29 | SELL | 6,500 | $654.27 | $4252.8K |
| McCourt Marion | EVP Commercial | 2024-11-01 | SELL | 1,000 | $844.61 | $844.6K |
| RYAN ARTHUR F | Director | 2024-10-01 | SELL | 100 | $1048.78 | $104.9K |
| McCourt Marion | EVP Commercial | 2024-10-01 | SELL | 1,000 | $1054.06 | $1054.1K |
| McCourt Marion | EVP Commercial | 2024-09-03 | SELL | 1,000 | $1178.73 | $1178.7K |
| RYAN ARTHUR F | Director | 2024-09-03 | SELL | 100 | $1178.69 | $117.9K |
| Fenimore Christopher R. | SVP Finance & CFO | 2024-08-28 | SELL | 5,680 | $1205.33 | $6846.3K |
| Bassler Bonnie L | Director | 2024-08-15 | SELL | 756 | $1170 | $884.5K |
| POON CHRISTINE A | Director | 2024-08-15 | SELL | 10,838 | $1158.17 | $12552.2K |
| MURPHY ANDREW J | EVP Research | 2024-08-14 | SELL | 6,363 | $1153.15 | $7337.5K |
| STAHL NEIL | EVP Research and Development | 2024-08-08 | SELL | 5,197 | $1084.54 | $5636.4K |
| Pitofsky Jason | VP Controller | 2024-08-07 | SELL | 487 | $1070 | $521.1K |
| Bassler Bonnie L | Director | 2024-08-02 | SELL | 756 | $1115 | $842.9K |
| RYAN ARTHUR F | Director | 2024-08-01 | SELL | 1 | $1100.03 | $1.1K |
| RYAN ARTHUR F | Director | 2024-08-01 | SELL | 99 | $1085.53 | $107.5K |
| McCourt Marion | EVP Commercial | 2024-08-01 | SELL | 1,137 | $1060.86 | $1206.2K |
| LAROSA JOSEPH J | EVP General Counsel and Secret | 2024-07-11 | SELL | 1,866 | $1088.95 | $2032K |
| McCourt Marion | EVP Commercial | 2024-07-01 | SELL | 1,137 | $1047.11 | $1190.6K |
| RYAN ARTHUR F | Director | 2024-07-01 | SELL | 100 | $1059.24 | $105.9K |
| Bassler Bonnie L | Director | 2024-06-24 | SELL | 756 | $1062 | $802.9K |
| BROWN MICHAEL S | Director | 2024-06-14 | SELL | 1,535 | $1040 | $1596.4K |
| SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 2024-06-12 | SELL | 25,213 | $1015.75 | $25610.1K |
| SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 2024-06-06 | SELL | 787 | $1015.02 | $798.8K |
| Bassler Bonnie L | Director | 2024-06-05 | SELL | 827 | $1011 | $836.1K |
| McCourt Marion | EVP Commercial | 2024-06-03 | SELL | 1,138 | $980.16 | $1115.4K |
| RYAN ARTHUR F | Director | 2024-06-03 | SELL | 100 | $994.5 | $99.5K |
| BROWN MICHAEL S | Director | 2024-05-28 | SELL | 1,172 | $974.86 | $1142.5K |
| LAROSA JOSEPH J | EVP General Counsel and Secret | 2024-05-21 | SELL | 1,865 | $994.9 | $1855.5K |
| SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 2024-05-17 | SELL | 22,830 | $979.23 | $22355.8K |
| YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 2024-05-16 | SELL | 50,000 | $972.73 | $48636.5K |
| SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 2024-05-15 | SELL | 35,941 | $979.58 | $35207.1K |
| McCourt Marion | EVP Commercial | 2024-05-01 | SELL | 250 | $889.41 | $222.4K |
| RYAN ARTHUR F | Director | 2024-05-01 | SELL | 100 | $899.61 | $90K |
| RYAN ARTHUR F | Director | 2024-04-01 | SELL | 100 | $962.53 | $96.3K |
| McCourt Marion | EVP Commercial | 2024-04-01 | SELL | 250 | $964.73 | $241.2K |
| MURPHY ANDREW J | EVP Research | 2024-03-14 | SELL | 5,783 | $956.47 | $5531.3K |
| RYAN ARTHUR F | Director | 2024-03-01 | SELL | 100 | $982.05 | $98.2K |
| McCourt Marion | EVP Commercial | 2024-03-01 | SELL | 358 | $967.5 | $346.4K |
| LAROSA JOSEPH J | EVP General Counsel and Secret | 2024-02-26 | SELL | 1,000 | $990 | $990K |
| SING GEORGE L | Director | 2024-02-26 | SELL | 1,000 | $992.5 | $992.5K |
| Bassler Bonnie L | Director | 2024-02-26 | SELL | 854 | $979.25 | $836.3K |
| SING GEORGE L | Director | 2024-02-23 | SELL | 3,500 | $967.86 | $3387.5K |
| LAROSA JOSEPH J | EVP General Counsel and Secret | 2024-02-22 | SELL | 1,000 | $967.65 | $967.7K |
| Van Plew Daniel P | EVP & General Mgr, Industrial | 2024-02-14 | SELL | 10,434 | $942.28 | $9831.7K |
| SING GEORGE L | Director | 2024-02-09 | SELL | 1,000 | $950 | $950K |
| Fenimore Christopher R. | SVP Finance & CFO | 2024-02-09 | SELL | 4,919 | $953.31 | $4689.3K |
| LAROSA JOSEPH J | EVP General Counsel and Secret | 2024-02-07 | SELL | 1,000 | $950 | $950K |
| STAHL NEIL | EVP Research and Development | 2024-02-07 | SELL | 8,037 | $950.35 | $7638K |
| McCourt Marion | EVP Commercial | 2024-02-05 | SELL | 1,000 | $934.71 | $934.7K |
| RYAN ARTHUR F | Director | 2024-02-01 | SELL | 100 | $954.22 | $95.4K |
| Bassler Bonnie L | Director | 2024-01-30 | SELL | 827 | $959 | $793.1K |
| GOLDSTEIN JOSEPH L | Director | 2024-01-23 | SELL | 2,707 | $950 | $2571.7K |
| Bassler Bonnie L | Director | 2024-01-03 | SELL | 826 | $914 | $755K |
| YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 2024-01-02 | SELL | 16,848 | $900 | $15163.2K |
| RYAN ARTHUR F | Director | 2024-01-02 | SELL | 100 | $899.9 | $90K |
| YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 2024-01-02 | SELL | 16,848 | $900 | $15163.2K |
| McCourt Marion | EVP Commercial | 2024-01-02 | SELL | 274 | $873.91 | $239.5K |
| Zoghbi Huda Y | Director | 2024-01-02 | SELL | 1,117 | $900 | $1005.3K |
| BROWN MICHAEL S | Director | 2023-12-27 | SELL | 2,049 | $898 | $1840K |
| Fenimore Christopher R. | SVP Controller | 2023-12-27 | SELL | 2,448 | $856.71 | $2097.2K |
| Fenimore Christopher R. | SVP Controller | 2023-12-22 | SELL | 1,930 | $844.3 | $1629.5K |
| Bassler Bonnie L | Director | 2023-12-13 | SELL | 610 | $870 | $530.7K |
| McCourt Marion | EVP Commercial | 2023-12-11 | SELL | 270 | $838.44 | $226.4K |
| MURPHY ANDREW J | EVP Research | 2023-12-05 | SELL | 6,536 | $817.44 | $5342.8K |
| RYAN ARTHUR F | Director | 2023-12-01 | SELL | 100 | $817.3 | $81.7K |
| MURPHY ANDREW J | EVP Research | 2023-11-14 | SELL | 6,492 | $799.17 | $5188.2K |
| RYAN ARTHUR F | Director | 2023-11-07 | SELL | 100 | $827.9 | $82.8K |
| McCourt Marion | EVP Commercial | 2023-11-01 | SELL | 1,000 | $783.91 | $783.9K |
| Zoghbi Huda Y | Director | 2023-10-13 | SELL | 1,000 | $850 | $850K |
| McCourt Marion | EVP Commercial | 2023-09-01 | SELL | 250 | $834.55 | $208.6K |
| Van Plew Daniel P | EVP & General Mgr, Industrial | 2023-08-24 | SELL | 6,197 | $841.71 | $5216.1K |
| Landry Robert E | EVP Finance CFO | 2023-08-23 | SELL | 223 | $844 | $188.2K |
| POON CHRISTINE A | Director | 2023-08-23 | SELL | 12,280 | $839.97 | $10314.8K |
| STAHL NEIL | EVP Research and Development | 2023-08-22 | SELL | 11,665 | $840.98 | $9810K |
| Bassler Bonnie L | Director | 2023-08-21 | SELL | 853 | $829 | $707.1K |
| Bassler Bonnie L | Director | 2023-08-10 | SELL | 853 | $789 | $673K |
| McCourt Marion | EVP Commercial | 2023-08-01 | SELL | 250 | $744.66 | $186.2K |
| RYAN ARTHUR F | Director | 2023-08-01 | SELL | 100 | $736.59 | $73.7K |
| McCourt Marion | EVP Commercial | 2023-07-03 | SELL | 250 | $710.09 | $177.5K |
| RYAN ARTHUR F | Director | 2023-07-03 | SELL | 100 | $716.88 | $71.7K |
| McCourt Marion | EVP Commercial | 2023-06-01 | SELL | 250 | $736 | $184K |
| RYAN ARTHUR F | Director | 2023-05-01 | SELL | 100 | $805.33 | $80.5K |
| BROWN MICHAEL S | Director | 2023-04-21 | SELL | 3,070 | $798.42 | $2451.1K |
| RYAN ARTHUR F | Director | 2023-04-03 | SELL | 100 | $819.31 | $81.9K |
| McCourt Marion | EVP Commercial | 2023-04-03 | SELL | 1,100 | $818.8 | $900.7K |
| Landry Robert E | EVP Finance CFO | 2023-03-28 | SELL | 1,190 | $823.2 | $979.6K |
| Bassler Bonnie L | Director | 2023-03-24 | SELL | 1,240 | $818 | $1014.3K |
| YANCOPOULOS GEORGE | President and Chief Scientific | 2023-03-23 | SELL | 3,656 | $804.26 | $2940.4K |
| Fenimore Christopher R. | SVP Controller | 2023-03-23 | SELL | 2,192 | $806.47 | $1767.8K |
| McCourt Marion | EVP Commercial | 2023-02-07 | SELL | 1,000 | $769.04 | $769K |
| Landry Robert E | EVP Finance CFO | 2023-02-06 | SELL | 1,491 | $776.8 | $1158.2K |
| GOLDSTEIN JOSEPH L | Director | 2023-02-06 | SELL | 3,613 | $800 | $2890.4K |
| BROWN MICHAEL S | Director | 2023-02-06 | SELL | 3,571 | $797.86 | $2849.2K |
| YANCOPOULOS GEORGE | President and Chief Scientific | 2023-02-06 | SELL | 13,189 | $800.08 | $10552.3K |
| Bassler Bonnie L | Director | 2023-02-03 | SELL | 1,021 | $779 | $795.4K |
| RYAN ARTHUR F | Director | 2023-02-01 | SELL | 100 | $756.13 | $75.6K |
| McCourt Marion | EVP Commercial | 2023-02-01 | SELL | 1,100 | $752.19 | $827.4K |
| BROWN MICHAEL S | Director | 2023-01-27 | SELL | 1 | $747 | $0.7K |
| BROWN MICHAEL S | Director | 2023-01-06 | SELL | 3,070 | $747.14 | $2293.7K |
| COLES N ANTHONY | Director | 2022-12-28 | SELL | 5,758 | $714.11 | $4111.8K |
| McCourt Marion | EVP Commercial | 2022-12-12 | SELL | 264 | $730.17 | $192.8K |
| Bassler Bonnie L | Director | 2022-12-08 | SELL | 218 | $779 | $169.8K |
| Landry Robert E | EVP Finance CFO | 2022-12-02 | SELL | 610 | $756.66 | $461.6K |
| RYAN ARTHUR F | Director | 2022-12-01 | SELL | 100 | $758.17 | $75.8K |
| McCourt Marion | EVP Commercial | 2022-12-01 | SELL | 1,100 | $756.19 | $831.8K |
| Van Plew Daniel P | EVP & General Mgr, Industrial | 2022-11-23 | SELL | 11,972 | $740.75 | $8868.3K |
| MURPHY ANDREW J | EVP Research | 2022-11-15 | SELL | 3,720 | $727.81 | $2707.5K |
| BROWN MICHAEL S | Director | 2022-11-08 | SELL | 4,495 | $754.44 | $3391.2K |
| Van Plew Daniel P | EVP & General Mgr, Industrial | 2022-11-07 | SELL | 7,886 | $745.4 | $5878.2K |
| McCourt Marion | EVP Commercial | 2022-11-04 | SELL | 1,000 | $727.82 | $727.8K |
| Landry Robert E | EVP Finance CFO | 2022-11-01 | SELL | 482 | $758.06 | $365.4K |
| McCourt Marion | EVP Commercial | 2022-11-01 | SELL | 1,100 | $750 | $825K |
| RYAN ARTHUR F | Director | 2022-11-01 | SELL | 100 | $755.89 | $75.6K |
| Landry Robert E | EVP Finance CFO | 2022-10-17 | SELL | 358 | $739.5 | $264.7K |
| Fenimore Christopher R. | SVP Controller | 2022-10-05 | SELL | 1,844 | $749 | $1381.2K |
| RYAN ARTHUR F | Director | 2022-10-03 | SELL | 100 | $726.54 | $72.7K |
| Tessier-Lavigne Marc | Director | 2022-10-03 | SELL | 10,838 | $702.24 | $7610.9K |
| McCourt Marion | EVP Commercial | 2022-10-03 | SELL | 1,100 | $705.39 | $775.9K |
| Fenimore Christopher R. | SVP Controller | 2022-10-03 | SELL | 3,346 | $724 | $2422.5K |
| Van Plew Daniel P | EVP & General Mgr, Industrial | 2022-09-12 | SELL | 4,696 | $716.38 | $3364.1K |
| Bassler Bonnie L | Director | 2022-09-09 | SELL | 3,167 | $704.65 | $2231.6K |
| RYAN ARTHUR F | Director | 2022-09-06 | SELL | 100 | $582.37 | $58.2K |
| COLES N ANTHONY | Director | 2022-09-06 | SELL | 6,000 | $581.28 | $3487.7K |
| McCourt Marion | EVP Commercial | 2022-09-01 | SELL | 1,100 | $577.62 | $635.4K |
| MURPHY ANDREW J | EVP Research | 2022-08-16 | SELL | 3,513 | $645.49 | $2267.6K |
| POON CHRISTINE A | Director | 2022-08-09 | SELL | 15,000 | $620.91 | $9313.7K |
| STAHL NEIL | EVP Research and Development | 2022-08-05 | SELL | 23,782 | $612.61 | $14569.1K |
| RYAN ARTHUR F | Director | 2022-08-04 | SELL | 10,453 | $621.29 | $6494.3K |
| McCourt Marion | EVP Commercial | 2022-08-01 | SELL | 1,100 | $581.53 | $639.7K |
| McCourt Marion | EVP Commercial | 2022-07-01 | SELL | 1,100 | $587.76 | $646.5K |
| MURPHY ANDREW J | EVP Research | 2022-05-17 | SELL | 3,543 | $663.68 | $2351.4K |
| RYAN ARTHUR F | Director | 2022-05-02 | SELL | 100 | $650.78 | $65.1K |
| McCourt Marion | EVP Commercial | 2022-05-02 | SELL | 1,100 | $656.97 | $722.7K |
| Landry Robert E | EVP Finance CFO | 2022-04-11 | SELL | 2,187 | $734.61 | $1606.6K |
| LAROSA JOSEPH J | EVP General Counsel and Secret | 2022-04-07 | SELL | 5,114 | $721.1 | $3687.7K |
| Bassler Bonnie L | Director | 2022-04-07 | SELL | 1,240 | $725 | $899K |
| SCHLEIFER LEONARD S | President & CEO | 2022-04-06 | SELL | 7,114 | $710.05 | $5051.3K |
| Landry Robert E | EVP Finance CFO | 2022-04-01 | SELL | 316 | $695.81 | $219.9K |
| BROWN MICHAEL S | Director | 2022-03-30 | SELL | 1,930 | $699 | $1349.1K |
| GOLDSTEIN JOSEPH L | Director | 2022-03-30 | SELL | 2,431 | $700 | $1701.7K |
| VAGELOS P ROY | Director | 2022-03-30 | SELL | 28,572 | $700.01 | $20000.7K |
| Bassler Bonnie L | Director | 2022-03-30 | SELL | 1,240 | $700 | $868K |
| Landry Robert E | EVP Finance CFO | 2022-03-29 | SELL | 2,683 | $687.9 | $1845.6K |
| Landry Robert E | EVP Finance CFO | 2022-03-21 | SELL | 300 | $693 | $207.9K |
| Tessier-Lavigne Marc | Director | 2022-03-21 | SELL | 7,439 | $690 | $5132.9K |
| Landry Robert E | EVP Finance CFO | 2022-03-17 | SELL | 383 | $678.95 | $260K |
| Tessier-Lavigne Marc | Director | 2022-03-17 | SELL | 12,191 | $678.21 | $8268.1K |
| Zoghbi Huda Y | Director | 2022-03-16 | SELL | 2,000 | $675 | $1350K |
| Van Plew Daniel P | EVP & General Mgr, Industrial | 2022-02-23 | SELL | 6,781 | $613.99 | $4163.5K |
| BROWN MICHAEL S | Director | 2022-02-23 | SELL | 500 | $608.68 | $304.3K |
| MURPHY ANDREW J | EVP Research | 2022-02-15 | SELL | 3,540 | $629.34 | $2227.9K |
| McCourt Marion | EVP Commercial | 2021-12-13 | SELL | 344 | $653.12 | $224.7K |
| Landry Robert E | EVP Finance CFO | 2021-12-13 | SELL | 116 | $662.5 | $76.9K |
| Landry Robert E | EVP Finance CFO | 2021-12-10 | SELL | 781 | $666.42 | $520.5K |
| MURPHY ANDREW J | EVP Research | 2021-12-10 | SELL | 7,122 | $666.27 | $4745.2K |
| Tessier-Lavigne Marc | Director | 2021-12-09 | SELL | 3,784 | $665 | $2516.4K |
| RYAN ARTHUR F | Director | 2021-12-01 | SELL | 100 | $637.53 | $63.8K |
| McCourt Marion | EVP Commercial | 2021-12-01 | SELL | 1,000 | $639.13 | $639.1K |
| SING GEORGE L | Director | 2021-11-22 | SELL | 3,000 | $656.67 | $1970K |
| Landry Robert E | EVP Finance CFO | 2021-11-17 | SELL | 681 | $645.08 | $439.3K |
| SING GEORGE L | Director | 2021-11-16 | SELL | 10,750 | $653.5 | $7025.1K |
| MURPHY ANDREW J | EVP Research | 2021-11-16 | SELL | 7,167 | $647.17 | $4638.3K |
| Van Plew Daniel P | EVP & General Mgr, Industrial | 2021-11-16 | SELL | 6,778 | $656.86 | $4452.2K |
| RYAN ARTHUR F | Director | 2021-11-01 | SELL | 100 | $642.52 | $64.3K |
| McCourt Marion | EVP Commercial | 2021-11-01 | SELL | 1,000 | $640 | $640K |
| RYAN ARTHUR F | Director | 2021-10-01 | SELL | 100 | $569.49 | $56.9K |
| McCourt Marion | EVP Commercial | 2021-10-01 | SELL | 1,000 | $576.75 | $576.8K |
| COLES N ANTHONY | Director | 2021-09-15 | SELL | 11,948 | $658.98 | $7873.5K |
| Zoghbi Huda Y | Director | 2021-09-14 | SELL | 1,000 | $650 | $650K |
| BROWN MICHAEL S | Director | 2021-09-13 | SELL | 9,704 | $648.16 | $6289.7K |
| Tessier-Lavigne Marc | Director | 2021-09-13 | SELL | 12,750 | $641.71 | $8181.8K |
| GOLDSTEIN JOSEPH L | Director | 2021-09-10 | SELL | 2,479 | $650 | $1611.4K |
| RYAN ARTHUR F | Director | 2021-09-01 | SELL | 100 | $676.28 | $67.6K |
| McCourt Marion | EVP Commercial | 2021-09-01 | SELL | 1,000 | $674.72 | $674.7K |
| SING GEORGE L | Director | 2021-08-30 | SELL | 1,700 | $672 | $1142.4K |
| POON CHRISTINE A | Director | 2021-08-27 | SELL | 15,000 | $668.09 | $10021.4K |
| LAROSA JOSEPH J | EVP General Counsel and Secret | 2021-08-23 | SELL | 3,425 | $661.84 | $2266.8K |
| Fenimore Christopher R. | SVP Controller | 2021-08-23 | SELL | 4,781 | $655.31 | $3133K |
| SCHLEIFER LEONARD S | President & CEO | 2021-08-19 | SELL | 210,000 | $650.51 | $136607.1K |
| VAGELOS P ROY | Director | 2021-08-18 | SELL | 10,039 | $650.04 | $6525.8K |
| COLES N ANTHONY | Director | 2021-08-18 | SELL | 6,000 | $650 | $3900K |
| SCHLEIFER LEONARD S | President & CEO | 2021-08-16 | SELL | 10,000 | $624.36 | $6243.6K |
| SING GEORGE L | Director | 2021-08-16 | SELL | 1,705 | $628.53 | $1071.6K |
| Bassler Bonnie L | Director | 2021-08-16 | SELL | 1,219 | $630 | $768K |
| YANCOPOULOS GEORGE | President and Chief Scientific | 2021-08-16 | SELL | 50,000 | $625.29 | $31264.5K |
| COLES N ANTHONY | Director | 2021-08-13 | SELL | 2,000 | $625 | $1250K |
| SING GEORGE L | Director | 2021-08-11 | SELL | 3,800 | $617.89 | $2348K |
| Landry Robert E | EVP Finance CFO | 2021-08-10 | SELL | 901 | $614.3 | $553.5K |
| Van Plew Daniel P | EVP & General Mgr, Industrial | 2021-08-10 | SELL | 6,603 | $611.86 | $4040.1K |
| BROWN MICHAEL S | Director | 2021-08-09 | SELL | 1,687 | $612.38 | $1033.1K |
| SING GEORGE L | Director | 2021-08-06 | SELL | 6,950 | $612.36 | $4255.9K |
| YANCOPOULOS GEORGE | President and Chief Scientific | 2021-08-05 | SELL | 50,000 | $600.06 | $30003K |
| Bassler Bonnie L | Director | 2021-08-05 | SELL | 2,559 | $600 | $1535.4K |
| RYAN ARTHUR F | Director | 2021-08-02 | SELL | 100 | $577.95 | $57.8K |
| McCourt Marion | EVP Commercial | 2021-08-02 | SELL | 1,000 | $577.12 | $577.1K |
| LAROSA JOSEPH J | EVP General Counsel and Secret | 2021-07-06 | SELL | 3,398 | $580 | $1970.8K |
| BROWN MICHAEL S | Director | 2021-06-25 | SELL | 2,084 | $549 | $1144.1K |
| YANCOPOULOS GEORGE | President and Chief Scientific | 2021-06-21 | SELL | 80,000 | $538.9 | $43112K |
| RYAN ARTHUR F | Director | 2021-06-14 | SELL | 100 | $524.76 | $52.5K |
| BROWN MICHAEL S | Director | 2021-06-14 | SELL | 1,700 | $525 | $892.5K |
| GOLDSTEIN JOSEPH L | Director | 2021-06-07 | SELL | 1,930 | $525 | $1013.3K |
| McCourt Marion | EVP Commercial | 2021-06-07 | SELL | 1,000 | $511.65 | $511.7K |
| McCourt Marion | EVP Commercial | 2021-05-07 | SELL | 1,000 | $495.63 | $495.6K |
| RYAN ARTHUR F | Director | 2021-02-01 | SELL | 100 | $506.92 | $50.7K |
| BROWN MICHAEL S | Director | 2021-01-25 | SELL | 2,480 | $554.32 | $1374.7K |
| RYAN ARTHUR F | Director | 2020-12-01 | SELL | 100 | $520.48 | $52K |
| MURPHY ANDREW J | EVP Research | 2020-11-17 | SELL | 6,628 | $542.73 | $3597.2K |
| RYAN ARTHUR F | Director | 2020-11-02 | SELL | 100 | $548.54 | $54.9K |
| GOLDSTEIN JOSEPH L | Director | 2020-10-05 | SELL | 9,212 | $600 | $5527.2K |
| McCourt Marion | SVP Commercial | 2020-10-05 | SELL | 2,000 | $606.08 | $1212.2K |
| RYAN ARTHUR F | Director | 2020-10-01 | SELL | 100 | $558.13 | $55.8K |
| BROWN MICHAEL S | Director | 2020-09-22 | SELL | 6,090 | $552.36 | $3363.9K |
| GOLDSTEIN JOSEPH L | Director | 2020-09-22 | SELL | 16,574 | $549.87 | $9113.5K |
| RYAN ARTHUR F | Director | 2020-09-01 | SELL | 100 | $604.58 | $60.5K |
| LAROSA JOSEPH J | EVP General Counsel and Secret | 2020-08-31 | SELL | 4,672 | $615.04 | $2873.5K |
| SING GEORGE L | Director | 2020-08-31 | SELL | 10,000 | $612.06 | $6120.6K |
| POON CHRISTINE A | Director | 2020-08-28 | SELL | 40,000 | $601.22 | $24048.8K |
| SING GEORGE L | Director | 2020-08-25 | SELL | 33,750 | $607.42 | $20500.4K |
| Van Plew Daniel P | EVP & General Mgr Industrial O | 2020-08-25 | SELL | 27,109 | $610.89 | $16560.6K |
| SING GEORGE L | Director | 2020-08-24 | SELL | 61,000 | $605.4 | $36929.4K |
| GOLDSTEIN JOSEPH L | Director | 2020-08-21 | SELL | 1,000 | $617.18 | $617.2K |
| VAGELOS P ROY | Director | 2020-08-11 | SELL | 33,460 | $602.94 | $20174.4K |
| Landry Robert E | EVP Finance CFO | 2020-08-04 | SELL | 696 | $654.46 | $455.5K |
| RYAN ARTHUR F | Director | 2020-08-03 | SELL | 100 | $641.93 | $64.2K |
| Fenimore Christopher R. | VP Controller | 2020-07-21 | SELL | 3,709 | $642.04 | $2381.3K |
| Landry Robert E | EVP Finance CFO | 2020-07-21 | SELL | 391 | $647.58 | $253.2K |
| Landry Robert E | EVP Finance CFO | 2020-07-14 | SELL | 579 | $640.5 | $370.8K |
| MURPHY ANDREW J | EVP Research | 2020-07-14 | SELL | 2,380 | $633.48 | $1507.7K |
| MURPHY ANDREW J | EVP Research | 2020-07-14 | SELL | 11,929 | $626.98 | $7479.2K |
| Landry Robert E | EVP Finance CFO | 2020-07-08 | SELL | 1,160 | $639.66 | $742K |
| SING GEORGE L | Director | 2020-07-07 | SELL | 10,500 | $650.05 | $6825.5K |
| Zoghbi Huda Y | Director | 2020-07-07 | SELL | 1,706 | $650 | $1108.9K |
| BROWN MICHAEL S | Director | 2020-07-01 | SELL | 3,613 | $607.62 | $2195.3K |
| RYAN ARTHUR F | Director | 2020-07-01 | SELL | 100 | $609.7 | $61K |
| Landry Robert E | EVP Finance CFO | 2020-06-29 | SELL | 400 | $612.57 | $245K |
| SING GEORGE L | Director | 2020-06-29 | SELL | 3,000 | $608.91 | $1826.7K |
| Landry Robert E | EVP Finance CFO | 2020-06-23 | SELL | 512 | $631.27 | $323.2K |
| Bassler Bonnie L | Director | 2020-06-19 | SELL | 2,559 | $630.02 | $1612.2K |
| Fenimore Christopher R. | VP Controller | 2020-06-16 | SELL | 3,556 | $590.89 | $2101.2K |
| Landry Robert E | EVP Finance CFO | 2020-06-11 | SELL | 988 | $612.08 | $604.7K |
| Zoghbi Huda Y | Director | 2020-06-11 | SELL | 3,412 | $617.62 | $2107.3K |
| Landry Robert E | EVP Finance CFO | 2020-06-09 | SELL | 4,271 | $608.01 | $2596.8K |
| Sanofi | 10% Owner | 2020-06-09 | SELL | 120,234 | $597.48 | $71837.4K |
| GOLDSTEIN JOSEPH L | Director | 2020-06-08 | SELL | 10,838 | $592.95 | $6426.4K |
| Bassler Bonnie L | Director | 2020-06-05 | SELL | 2,559 | $600 | $1535.4K |
| RYAN ARTHUR F | Director | 2020-06-01 | SELL | 100 | $603.23 | $60.3K |
| SING GEORGE L | Director | 2020-05-29 | SELL | 2,000 | $587.76 | $1175.5K |
| Sanofi | 10% Owner | 2020-05-29 | SELL | 22,821,451 | $509.85 | $11635516.8K |
| GOLDSTEIN JOSEPH L | Director | 2020-05-28 | SELL | 1,000 | $578.94 | $578.9K |
| VAGELOS P ROY | Chairman of the Board | 2020-05-21 | SELL | 783 | $577.49 | $452.2K |
| VAGELOS P ROY | Chairman of the Board | 2020-05-21 | SELL | 148,811 | $564.37 | $83984.5K |
| LAROSA JOSEPH J | EVP General Counsel and Secret | 2020-05-15 | SELL | 8,380 | $572 | $4793.4K |
| SCHLEIFER LEONARD S | President & CEO | 2020-05-12 | SELL | 150,922 | $569.22 | $85907.8K |
| STAHL NEIL | EVP Research and Development | 2020-05-11 | SELL | 5,305 | $569.52 | $3021.3K |
| SING GEORGE L | Director | 2020-05-11 | SELL | 5,850 | $579.27 | $3388.7K |
| BROWN MICHAEL S | Director | 2020-05-07 | SELL | 1,809 | $562 | $1016.7K |
| Van Plew Daniel P | EVP & General Mgr Industrial O | 2020-05-07 | SELL | 39,583 | $564.32 | $22337.5K |
| Zoghbi Huda Y | Director | 2020-05-07 | SELL | 5,118 | $566.52 | $2899.4K |
| Tessier-Lavigne Marc | Director | 2020-05-06 | SELL | 15,000 | $563.97 | $8459.6K |
| GOLDSTEIN JOSEPH L | Director | 2020-05-06 | SELL | 2,000 | $560 | $1120K |
| RYAN ARTHUR F | Director | 2020-05-06 | SELL | 50,124 | $550.88 | $27612.3K |
| RYAN ARTHUR F | Director | 2020-05-01 | SELL | 100 | $520.37 | $52K |
| Landry Robert E | EVP Finance CFO | 2020-04-20 | SELL | 4,241 | $564.77 | $2395.2K |
| LAROSA JOSEPH J | EVP General Counsel and Secret | 2020-04-20 | SELL | 1,778 | $570.3 | $1014K |
| LAROSA JOSEPH J | EVP General Counsel and Secret | 2020-04-20 | SELL | 5,789 | $562.31 | $3255.2K |
| LAROSA JOSEPH J | EVP General Counsel and Secret | 2020-04-15 | SELL | 2,262 | $518.21 | $1172.2K |
| Landry Robert E | EVP Finance CFO | 2020-04-15 | SELL | 853 | $518.49 | $442.3K |
| STAHL NEIL | EVP Research and Development | 2020-04-14 | SELL | 5,497 | $521.07 | $2864.3K |
| Landry Robert E | EVP Finance CFO | 2020-04-13 | SELL | 828 | $509.79 | $422.1K |
| Landry Robert E | EVP Finance CFO | 2020-04-07 | SELL | 696 | $497.52 | $346.3K |
| Landry Robert E | EVP Finance CFO | 2020-04-03 | SELL | 788 | $494.49 | $389.7K |
| Landry Robert E | EVP Finance CFO | 2020-04-02 | SELL | 1,848 | $488.9 | $903.5K |
| LAROSA JOSEPH J | EVP General Counsel and Secret | 2020-04-02 | SELL | 6,797 | $489.98 | $3330.4K |
| RYAN ARTHUR F | Director | 2020-04-01 | SELL | 200 | $475.27 | $95.1K |
| Fenimore Christopher R. | VP Controller | 2020-04-01 | SELL | 1,200 | $488.41 | $586.1K |
| YANCOPOULOS GEORGE | President and Chief Scientific | 2020-03-10 | SELL | 117,815 | $470.47 | $55428.4K |
| Sanofi | 10% Owner | 2020-03-09 | SELL | 128,914 | $489.65 | $63122.7K |
| GOLDSTEIN JOSEPH L | Director | 2020-03-09 | SELL | 2,000 | $475.84 | $951.7K |
| STAHL NEIL | EVP Research and Development | 2020-02-27 | SELL | 10,349 | $452.26 | $4680.4K |
| SING GEORGE L | Director | 2020-02-26 | SELL | 4,900 | $456.49 | $2236.8K |
| Van Plew Daniel P | EVP & General Mgr Industrial O | 2020-02-26 | SELL | 15,642 | $457.23 | $7152K |
| Landry Robert E | EVP Finance CFO | 2020-02-26 | SELL | 414 | $452.49 | $187.3K |
| YANCOPOULOS GEORGE | President and Chief Scientific | 2020-02-24 | SELL | 118,123 | $420.17 | $49631.7K |
| BROWN MICHAEL S | Director | 2020-02-24 | SELL | 2,000 | $419 | $838K |
| Tessier-Lavigne Marc | Director | 2020-02-13 | SELL | 14,279 | $400.01 | $5711.7K |
| Landry Robert E | EVP Finance CFO | 2020-02-13 | SELL | 107 | $400.05 | $42.8K |
| STAHL NEIL | EVP Research and Development | 2020-02-13 | SELL | 10,278 | $400.66 | $4118K |
| GOLDSTEIN JOSEPH L | Director | 2020-02-07 | SELL | 1,000 | $382.83 | $382.8K |
| MURPHY ANDREW J | EVP Research | 2020-01-27 | SELL | 8,000 | $340.91 | $2727.3K |
| SING GEORGE L | Director | 2020-01-02 | SELL | 15,000 | $371.98 | $5579.7K |
| Fenimore Christopher R. | VP Controller | 2019-12-13 | SELL | 1,682 | $376.14 | $632.7K |
| BROWN MICHAEL S | Director | 2019-12-13 | SELL | 4,000 | $373.99 | $1496K |
| VAGELOS P ROY | Chairman of the Board | 2019-12-13 | SELL | 51,842 | $376.04 | $19494.7K |
| GOLDSTEIN JOSEPH L | Director | 2019-11-27 | SELL | 1,000 | $370 | $370K |
| STAHL NEIL | EVP Research and Development | 2019-11-26 | SELL | 4,006 | $364.07 | $1458.5K |
| VAGELOS P ROY | Chairman of the Board | 2019-11-25 | SELL | 22,149 | $363.87 | $8059.4K |
| GOLDSTEIN JOSEPH L | Director | 2019-11-22 | SELL | 2,000 | $355 | $710K |
| BROWN MICHAEL S | Director | 2019-11-12 | SELL | 4,500 | $349 | $1570.5K |
| STAHL NEIL | EVP Research and Development | 2019-11-08 | SELL | 7,364 | $338.52 | $2492.9K |
| GOLDSTEIN JOSEPH L | Director | 2019-11-08 | SELL | 1,000 | $340.44 | $340.4K |
| Sanofi | 10% Owner | 2019-09-10 | SELL | 172,904 | $281.15 | $48612K |
| GOLDSTEIN JOSEPH L | Director | 2019-05-15 | SELL | 1,000 | $305.93 | $305.9K |
| STAHL NEIL | EVP Research and Development | 2019-05-14 | SELL | 9,853 | $305.74 | $3012.5K |
| Sanofi | 10% Owner | 2019-03-08 | SELL | 131,115 | $412.17 | $54041.7K |
| GOLDSTEIN JOSEPH L | Director | 2019-01-10 | SELL | 1,791 | $410 | $734.3K |
| Fenimore Christopher R. | VP Controller | 2018-12-20 | SELL | 1,848 | $358.97 | $663.4K |
| VAGELOS P ROY | Chairman of the Board | 2018-12-12 | SELL | 6 | $382.32 | $2.3K |
| GOLDSTEIN JOSEPH L | Director | 2018-09-28 | SELL | 2,709 | $402.62 | $1090.7K |
| BROWN MICHAEL S | Director | 2018-09-27 | SELL | 2,000 | $392.26 | $784.5K |
| GOLDSTEIN JOSEPH L | Director | 2018-09-24 | SELL | 2,000 | $388.65 | $777.3K |
| Sanofi | 10% Owner | 2018-09-06 | SELL | 104,552 | $406.68 | $42519.2K |
| BROWN MICHAEL S | Director | 2018-08-22 | SELL | 1,500 | $380.49 | $570.7K |
| GOLDSTEIN JOSEPH L | Director | 2018-08-02 | SELL | 2,000 | $380 | $760K |
| VAGELOS P ROY | Chairman of the Board | 2018-07-10 | SELL | 74,670 | $367.22 | $27420.3K |
| GOLDSTEIN JOSEPH L | Director | 2018-07-06 | SELL | 4,000 | $365 | $1460K |
| VAGELOS P ROY | Chairman of the Board | 2018-06-21 | SELL | 74,710 | $327.87 | $24495.2K |
| Sanofi | 10% Owner | 2018-06-08 | SELL | 121,601 | $309.31 | $37612.4K |
| STAHL NEIL | EVP Research and Development | 2018-05-24 | SELL | 11,407 | $295.09 | $3366.1K |
| SING GEORGE L | Director | 2018-05-10 | SELL | 20,000 | $286.15 | $5723K |
| GOLDSTEIN JOSEPH L | Director | 2018-03-19 | SELL | 2,000 | $350.02 | $700K |
| GOLDSTEIN JOSEPH L | Director | 2018-03-14 | SELL | 2,000 | $340 | $680K |
| GOLDSTEIN JOSEPH L | Director | 2018-02-09 | SELL | 1,000 | $325.6 | $325.6K |
| BROWN MICHAEL S | Director | 2017-10-05 | SELL | 1,500 | $475 | $712.5K |
| BAKER CHARLES A | Director | 2017-09-29 | SELL | 2,000 | $450 | $900K |
| Landry Robert E | SVP Finance & CFO | 2017-09-06 | SELL | 663 | $498.6 | $330.6K |
| Landry Robert E | SVP Finance & CFO | 2017-08-31 | SELL | 427 | $493.43 | $210.7K |
| Sanofi | 10% Owner | 2017-08-25 | BUY | 72,378 | $481.36 | $34839.9K |
| Sanofi | 10% Owner | 2017-08-24 | BUY | 166,415 | $480.93 | $80034K |
| Landry Robert E | SVP Finance & CFO | 2017-08-23 | SELL | 468 | $476.45 | $223K |
| VAGELOS P ROY | Chairman of the Board | 2017-08-22 | SELL | 56,213 | $474.48 | $26671.9K |
| VAGELOS P ROY | Chairman of the Board | 2017-08-18 | SELL | 15,191 | $470.15 | $7142K |
| Landry Robert E | SVP Finance & CFO | 2017-08-08 | SELL | 526 | $472.19 | $248.4K |
| Aberman Michael S | SVP Strategy Investor Relation | 2017-06-22 | SELL | 2,269 | $532.42 | $1208.1K |
| STAHL NEIL | EVP Research and Development | 2017-06-22 | SELL | 8,306 | $532.55 | $4423.4K |
| GOLDSTEIN JOSEPH L | Director | 2017-06-20 | SELL | 1,000 | $500.01 | $500K |
| BROWN MICHAEL S | Director | 2017-06-20 | SELL | 3,000 | $500 | $1500K |
| Terifay Robert J | EVP Commercial | 2017-06-16 | SELL | 21,147 | $468.19 | $9900.8K |
| STAHL NEIL | EVP Research and Development | 2017-06-15 | SELL | 8,567 | $468.45 | $4013.2K |
| BROWN MICHAEL S | Director | 2017-06-12 | SELL | 2,000 | $474.45 | $948.9K |
| GOLDSTEIN JOSEPH L | Director | 2017-06-09 | SELL | 1,000 | $482.55 | $482.6K |
| Sanofi | 10% Owner | 2017-06-02 | BUY | 136,050 | $478.17 | $65055K |
| STAHL NEIL | EVP Research and Development | 2017-06-02 | SELL | 2,812 | $479.49 | $1348.3K |
| VAGELOS P ROY | Chairman of the Board | 2017-05-25 | SELL | 9,295 | $458.14 | $4258.4K |
| BROWN MICHAEL S | Director | 2017-05-12 | SELL | 3,000 | $450 | $1350K |
| BROWN MICHAEL S | Director | 2017-03-29 | SELL | 1,000 | $400 | $400K |
| Sanofi | 10% Owner | 2017-01-11 | BUY | 87,298 | $369.71 | $32274.9K |
| BAKER CHARLES A | Director | 2016-12-12 | SELL | 3,000 | $392.02 | $1176.1K |
| RYAN ARTHUR F | Director | 2016-11-15 | SELL | 2,000 | $429.34 | $858.7K |
| GOLDSTEIN JOSEPH L | Director | 2016-11-14 | SELL | 2,125 | $450 | $956.3K |
| GOLDSTEIN JOSEPH L | Director | 2016-07-29 | SELL | 2,125 | $425 | $903.1K |
| Sanofi | 10% Owner | 2016-06-14 | BUY | 64,731 | $363.86 | $23553K |
| RYAN ARTHUR F | Director | 2016-05-24 | SELL | 1,000 | $396.64 | $396.6K |
| Van Plew Daniel P | EVP & General Mgr Industrial O | 2016-05-18 | SELL | 4,413 | $385.77 | $1702.4K |
| GOLDSTEIN JOSEPH L | Director | 2016-04-06 | SELL | 2,000 | $425 | $850K |
| GOLDSTEIN JOSEPH L | Director | 2016-03-21 | SELL | 2,000 | $375 | $750K |
| Sanofi | 10% Owner | 2016-02-17 | BUY | 161,157 | $392.46 | $63247.7K |
| Sanofi | 10% Owner | 2016-01-12 | BUY | 83,938 | $465.04 | $39034.5K |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2015-12-29 | SELL | 3,954 | $552.08 | $2182.9K |
| BROWN MICHAEL S | Director | 2015-12-10 | SELL | 3,000 | $546.45 | $1639.4K |
| YANCOPOULOS GEORGE | President Regeneron Laboratori | 2015-12-02 | SELL | 43,348 | $549.03 | $23799.4K |
| VAGELOS P ROY | Chairman of the Board | 2015-11-18 | SELL | 17,240 | $587.9 | $10135.4K |
| SING GEORGE L | Director | 2015-11-18 | SELL | 3,500 | $580 | $2030K |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2015-11-10 | SELL | 5,123 | $554.85 | $2842.5K |
| STAHL NEIL | EVP Research and Development | 2015-11-09 | SELL | 42,101 | $561.45 | $23637.6K |
| VAGELOS P ROY | Chairman of the Board | 2015-11-03 | SELL | 17,242 | $580.19 | $10003.6K |
| YANCOPOULOS GEORGE | President Regeneron Laboratori | 2015-11-02 | SELL | 43,348 | $571.61 | $24778.2K |
| Sanofi | 10% Owner | 2015-10-06 | BUY | 11,040 | $472.33 | $5214.5K |
| Sanofi | 10% Owner | 2015-10-06 | BUY | 80,538 | $459.71 | $37024.1K |
| Sanofi | 10% Owner | 2015-09-23 | BUY | 147,209 | $534.67 | $78708.2K |
| BROWN MICHAEL S | Director | 2015-09-21 | SELL | 3,000 | $551.55 | $1654.7K |
| BAKER CHARLES A | Director | 2015-09-17 | SELL | 5,000 | $550 | $2750K |
| Powchik Peter | SVP Clinical Development & Reg | 2015-08-14 | SELL | 23,485 | $573.38 | $13465.8K |
| POON CHRISTINE A | Director | 2015-08-12 | SELL | 112 | $564.16 | $63.2K |
| GILMAN ALFRED G | Director | 2015-08-06 | SELL | 5,000 | $587.12 | $2935.6K |
| Terifay Robert J | SVP Commercial | 2015-08-06 | SELL | 13,423 | $588.97 | $7905.7K |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2015-08-06 | SELL | 4,028 | $584.36 | $2353.8K |
| Landry Robert E | SVP Finance & CFO | 2015-08-05 | SELL | 4,000 | $592.84 | $2371.4K |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2015-08-05 | SELL | 5,000 | $585.53 | $2927.7K |
| Tessier-Lavigne Marc | Director | 2015-08-05 | SELL | 5,000 | $590.26 | $2951.3K |
| GOLDSTEIN JOSEPH L | Director | 2015-08-04 | SELL | 2,000 | $586 | $1172K |
| Sanofi | 10% Owner | 2015-07-27 | BUY | 10,639 | $537.48 | $5718.2K |
| GOLDSTEIN JOSEPH L | Director | 2015-07-15 | SELL | 2,000 | $550 | $1100K |
| GOLDSTEIN JOSEPH L | Director | 2015-06-22 | SELL | 2,000 | $526.85 | $1053.7K |
| INGRAM ROBERT ALEXANDER | Director | 2015-05-27 | SELL | 1,379 | $513.39 | $708K |
| SING GEORGE L | Director | 2015-05-27 | SELL | 5,000 | $515 | $2575K |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2015-05-26 | SELL | 18,370 | $508.42 | $9339.7K |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2015-05-22 | SELL | 13,000 | $515.6 | $6702.8K |
| GOLDSTEIN JOSEPH L | Director | 2015-05-22 | SELL | 4,000 | $514.28 | $2057.1K |
| BROWN MICHAEL S | Director | 2015-05-15 | SELL | 5,000 | $495 | $2475K |
| BAKER CHARLES A | Director | 2015-03-25 | SELL | 5,000 | $454.96 | $2274.8K |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-24 | SELL | 4,843 | $478.99 | $2319.7K |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-03-18 | SELL | 3,442 | $465 | $1600.5K |
| Terifay Robert J | SVP Commercial | 2015-03-17 | SELL | 10,993 | $451.01 | $4958K |
| LAROSA JOSEPH J | SVP General Counsel and Secret | 2015-03-16 | SELL | 18,311 | $450 | $8240K |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2015-02-27 | SELL | 3,000 | $416.24 | $1248.7K |
| Tessier-Lavigne Marc | Director | 2015-02-26 | SELL | 3,000 | $421.95 | $1265.9K |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-02-24 | SELL | 3,374 | $418.48 | $1412K |
| Terifay Robert J | SVP Commercial | 2015-02-24 | SELL | 11,173 | $423.67 | $4733.7K |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2015-02-23 | SELL | 9,431 | $427.82 | $4034.8K |
| SING GEORGE L | Director | 2015-02-20 | SELL | 15,000 | $423.12 | $6346.8K |
| BROWN MICHAEL S | Director | 2015-02-20 | SELL | 1,000 | $422.72 | $422.7K |
| RYAN ARTHUR F | Director | 2015-02-20 | SELL | 29,250 | $423.01 | $12373K |
| GOLDSTEIN JOSEPH L | Director | 2015-02-20 | SELL | 5,000 | $423.65 | $2118.3K |
| Aberman Michael S | SVP Strategy Investor Relation | 2015-02-17 | SELL | 3,692 | $404.46 | $1493.3K |
| Powchik Peter | SVP Clinical Development & Reg | 2015-01-02 | SELL | 10,822 | $414.08 | $4481.2K |
| SCHLEIFER LEONARD S | President & CEO | 2015-01-02 | SELL | 1,500 | $410.58 | $615.9K |
| Sanofi | 10% Owner | 2014-12-24 | BUY | 201,459 | $393.21 | $79215.7K |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2014-12-16 | SELL | 8,486 | $410.15 | $3480.5K |
| POON CHRISTINE A | Director | 2014-11-25 | BUY | 400 | $410 | $164K |
| GILMAN ALFRED G | Director | 2014-11-24 | SELL | 40,000 | $408.44 | $16337.6K |
| STAHL NEIL | SVP Research and Development S | 2014-11-24 | SELL | 5,307 | $412.93 | $2191.4K |
| Terifay Robert J | SVP Commercial | 2014-11-18 | SELL | 22,362 | $405.79 | $9074.3K |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2014-11-13 | SELL | 8,575 | $399.34 | $3424.3K |
| GOLDSTEIN JOSEPH L | Director | 2014-11-12 | SELL | 5,000 | $398.31 | $1991.6K |
| SCHLEIFER LEONARD S | President & CEO | 2014-11-12 | SELL | 45,817 | $400.3 | $18340.5K |
| SCHLEIFER LEONARD S | President & CEO | 2014-10-31 | SELL | 3,453 | $400.11 | $1381.6K |
| SCHLEIFER LEONARD S | President & CEO | 2014-10-28 | SELL | 69,112 | $404.01 | $27921.9K |
| BROWN MICHAEL S | Director | 2014-10-24 | SELL | 5,000 | $399 | $1995K |
| GOLDBERG MURRAY A | SVP Administration & Asst Secr | 2014-10-24 | SELL | 26,788 | $400.7 | $10734K |
| Sanofi | 10% Owner | 2014-10-16 | BUY | 122,127 | $335.35 | $40955.3K |
| Sanofi | 10% Owner | 2014-10-15 | BUY | 158,368 | $328.16 | $51970K |
| Sanofi | 10% Owner | 2014-09-16 | BUY | 31,717 | $349.26 | $11077.5K |
| Sanofi | 10% Owner | 2014-09-15 | BUY | 140,632 | $345.15 | $48539.1K |
| VAGELOS P ROY | Chairman of the Board | 2014-09-10 | SELL | 10,328 | $350.07 | $3615.5K |
| Tessier-Lavigne Marc | Director | 2014-08-27 | SELL | 3,000 | $352.2 | $1056.6K |
| GOLDSTEIN JOSEPH L | Director | 2014-08-27 | SELL | 2,000 | $350.31 | $700.6K |
| Aberman Michael S | VP Strategy and Investor Relat | 2014-08-19 | SELL | 3,611 | $350 | $1263.9K |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2014-08-18 | SELL | 5,875 | $353 | $2073.9K |
| BROWN MICHAEL S | Director | 2014-08-15 | SELL | 3,000 | $349.2 | $1047.6K |
| GOLDSTEIN JOSEPH L | Director | 2014-08-14 | SELL | 2,000 | $347.65 | $695.3K |
| VAGELOS P ROY | Chairman of the Board | 2014-08-13 | SELL | 8,028 | $340.01 | $2729.6K |
| STAHL NEIL | SVP Research and Development S | 2014-08-11 | SELL | 11,646 | $339.96 | $3959.2K |
| VAGELOS P ROY | Chairman of the Board | 2014-08-11 | SELL | 11,972 | $340.11 | $4071.8K |
| STAHL NEIL | SVP Research and Development S | 2014-08-08 | SELL | 2,841 | $340.6 | $967.6K |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2014-08-07 | SELL | 6,806 | $338.37 | $2302.9K |
| GOLDSTEIN JOSEPH L | Director | 2014-08-06 | SELL | 2,000 | $331.2 | $662.4K |
| Sanofi | 10% Owner | 2014-07-15 | BUY | 129,100 | $314.92 | $40656.2K |
| Sanofi | 10% Owner | 2014-07-14 | BUY | 300,000 | $316.8 | $95040K |
| Sanofi | 10% Owner | 2014-07-10 | BUY | 175,000 | $311.08 | $54439K |
| Sanofi | 10% Owner | 2014-07-09 | BUY | 348,000 | $309.76 | $107796.5K |
| Sanofi | 10% Owner | 2014-07-07 | BUY | 356,700 | $312.37 | $111422.4K |
| Sanofi | 10% Owner | 2014-07-02 | BUY | 212,400 | $307.25 | $65259.9K |
| Sanofi | 10% Owner | 2014-07-01 | BUY | 212,400 | $300.2 | $63762.5K |
| Sanofi | 10% Owner | 2014-06-30 | BUY | 262,400 | $281.17 | $73779K |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2014-05-23 | SELL | 5,369 | $295.93 | $1588.8K |
| POON CHRISTINE A | Director | 2014-05-21 | BUY | 255 | $291.9 | $74.4K |
| Sanofi | 10% Owner | 2014-05-19 | BUY | 190,751 | $300.04 | $57232.9K |
| Sanofi | 10% Owner | 2014-03-28 | BUY | 306,945 | $306.73 | $94149.2K |
| Sanofi | 10% Owner | 2014-03-27 | BUY | 306,945 | $311.01 | $95463K |
| Sanofi | 10% Owner | 2014-03-24 | BUY | 306,945 | $307.91 | $94511.4K |
| BAKER CHARLES A | Director | 2014-03-24 | SELL | 15,000 | $302.67 | $4540.1K |
| Sanofi | 10% Owner | 2014-03-21 | BUY | 305,115 | $321.22 | $98009K |
| Sanofi | 10% Owner | 2014-03-20 | BUY | 67,703 | $328.33 | $22228.9K |
| BROWN MICHAEL S | Director | 2014-03-17 | SELL | 2,000 | $334.29 | $668.6K |
| Sanofi | 10% Owner | 2014-03-17 | BUY | 115,711 | $328.46 | $38006.4K |
| Sanofi | 10% Owner | 2014-03-12 | BUY | 220,995 | $334.69 | $73964.8K |
| Sanofi | 10% Owner | 2014-03-11 | BUY | 380,532 | $330.41 | $125731.6K |
| Sanofi | 10% Owner | 2014-03-07 | BUY | 241,818 | $332.51 | $80406.9K |
| Sanofi | 10% Owner | 2014-03-07 | BUY | 150,277 | $328.72 | $49399.1K |
| Sanofi | 10% Owner | 2014-03-03 | BUY | 251,594 | $338.12 | $85069K |
| BROWN MICHAEL S | Director | 2014-02-27 | SELL | 1,000 | $335 | $335K |
| GOLDBERG MURRAY A | SVP Administration & Asst Secr | 2014-02-25 | SELL | 11,871 | $339.55 | $4030.8K |
| GOLDSTEIN JOSEPH L | Director | 2014-02-25 | SELL | 1,000 | $338.86 | $338.9K |
| SING GEORGE L | Director | 2014-02-21 | SELL | 15,000 | $339 | $5085K |
| GILMAN ALFRED G | Director | 2014-02-21 | SELL | 5,000 | $340 | $1700K |
| GOLDBERG MURRAY A | SVP Administration & Asst Secr | 2014-02-21 | SELL | 21,258 | $336.51 | $7153.5K |
| GOLDSTEIN JOSEPH L | Director | 2014-02-20 | SELL | 1,000 | $326.99 | $327K |
| Aberman Michael S | VP Strategy and Investor Relat | 2014-02-18 | SELL | 3,648 | $331.42 | $1209K |
| Terifay Robert J | SVP Commercial | 2014-02-18 | SELL | 12,865 | $332.68 | $4279.9K |
| SING GEORGE L | Director | 2014-02-14 | SELL | 15,000 | $324 | $4860K |
| STAHL NEIL | SVP Research and Development S | 2014-02-13 | SELL | 22,612 | $318.82 | $7209.2K |
| SHOOTER ERIC M | Director | 2014-02-12 | SELL | 15,000 | $320.52 | $4807.8K |
| GOLDSTEIN JOSEPH L | Director | 2014-02-12 | SELL | 1,000 | $320.62 | $320.6K |
| YANCOPOULOS GEORGE | President Regeneron Laboratori | 2014-02-12 | SELL | 88,987 | $320.33 | $28505.2K |
| GILMAN ALFRED G | Director | 2014-02-11 | SELL | 5,000 | $320 | $1600K |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2014-02-11 | SELL | 5,819 | $325 | $1891.2K |
| VAGELOS P ROY | Chairman of the Board | 2014-02-11 | SELL | 11,475 | $325.1 | $3730.5K |
| Sanofi | 10% Owner | 2014-02-07 | BUY | 168,511 | $286.78 | $48325.6K |
| Sanofi | 10% Owner | 2014-02-05 | BUY | 397,264 | $284.12 | $112870.6K |
| Sanofi | 10% Owner | 2014-02-03 | BUY | 208,972 | $283.78 | $59302.1K |
| Sanofi | 10% Owner | 2014-01-28 | BUY | 157,920 | $275.9 | $43570.1K |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2014-01-14 | SELL | 4,000 | $290 | $1160K |
| GILMAN ALFRED G | Director | 2014-01-14 | SELL | 5,000 | $300 | $1500K |
| Powchik Peter | SVP Clinical Development & Reg | 2014-01-02 | SELL | 20,668 | $274.77 | $5678.9K |
| Powchik Peter | SVP Clinical Development & Reg | 2013-12-20 | SELL | 9,133 | $270.21 | $2467.8K |
| Powchik Peter | SVP Clinical Development & Reg | 2013-12-17 | SELL | 8 | $270 | $2.2K |
| VAGELOS P ROY | Chairman of the Board | 2013-12-02 | SELL | 95 | $296.11 | $28.1K |
| SING GEORGE L | Director | 2013-11-26 | SELL | 10,000 | $295 | $2950K |
| GOLDSTEIN JOSEPH L | Director | 2013-11-06 | SELL | 1,000 | $300.74 | $300.7K |
| SCHLEIFER LEONARD S | President & CEO | 2013-10-02 | SELL | 9,162 | $313.82 | $2875.2K |
| BAKER CHARLES A | Director | 2013-09-30 | SELL | 15,000 | $314.03 | $4710.5K |
| BROWN MICHAEL S | Director | 2013-09-26 | SELL | 10,000 | $301.32 | $3013.2K |
| VAGELOS P ROY | Chairman of the Board | 2013-09-19 | SELL | 145,356 | $302.86 | $44022.5K |
| SCHLEIFER LEONARD S | President & CEO | 2013-09-19 | SELL | 102,949 | $302.67 | $31159.6K |
| ROBERTS WILLIAM | VP Reg Dev & Med Safety | 2013-09-18 | SELL | 15,000 | $304 | $4560K |
| Van Plew Daniel P | SVP & Gen Mgr IOPS | 2013-09-18 | SELL | 23,977 | $303.17 | $7269.1K |
| SCHLEIFER LEONARD S | CEO & President | 2013-09-09 | SELL | 5,000 | $275.47 | $1377.4K |
| GOLDSTEIN JOSEPH L | Director | 2013-08-23 | SELL | 1,000 | $238.29 | $238.3K |
| RYAN ARTHUR F | Director | 2013-08-23 | SELL | 10,958 | $238.47 | $2613.2K |
| BAKER CHARLES A | Director | 2013-06-10 | SELL | 15,000 | $251.84 | $3777.6K |
| RYAN ARTHUR F | Director | 2013-05-31 | SELL | 2,500 | $249.55 | $623.9K |
| GOLDSTEIN JOSEPH L | Director | 2013-05-28 | SELL | 4,000 | $252.2 | $1008.8K |
| GOLDBERG MURRAY A | SVP Finance and Admin CFO and | 2013-05-21 | SELL | 66,835 | $259.74 | $17359.7K |
| BROWN MICHAEL S | Director | 2013-05-17 | SELL | 15,000 | $275.19 | $4127.9K |
| Aberman Michael S | VP Strategy and Investor Relat | 2013-05-14 | SELL | 5,529 | $279.61 | $1546K |
| STAHL NEIL | SVP Research and Development S | 2013-05-13 | SELL | 23,038 | $276.88 | $6378.8K |
| SING GEORGE L | Director | 2013-05-10 | SELL | 5,000 | $270 | $1350K |
| Terifay Robert J | SVP Commercial | 2013-05-08 | SELL | 8,231 | $261.23 | $2150.2K |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2013-05-07 | SELL | 13,725 | $261.61 | $3590.6K |
| YANCOPOULOS GEORGE | President Regeneron Laboratori | 2013-05-07 | SELL | 100,000 | $262.64 | $26264K |
| Aberman Michael S | VP Strategy and Investor Relat | 2013-05-06 | SELL | 8,334 | $257.13 | $2142.9K |
| GILMAN ALFRED G | Director | 2013-05-06 | SELL | 30,000 | $261.04 | $7831.2K |
| SHOOTER ERIC M | Director | 2013-05-06 | SELL | 30,000 | $260.23 | $7806.9K |
| Tessier-Lavigne Marc | Director | 2013-05-06 | SELL | 13,334 | $260.91 | $3479K |
| VAGELOS P ROY | Chairman of the Board | 2013-05-06 | SELL | 13,482 | $263.21 | $3548.6K |
| VAGELOS P ROY | Chairman of the Board | 2013-05-06 | SELL | 12,018 | $263.15 | $3162.5K |
| McCorkle Douglas S | VP Controller & Asst Treasurer | 2013-05-02 | SELL | 2,213 | $244.79 | $541.7K |
| SCHLEIFER LEONARD S | President & CEO | 2013-05-01 | SELL | 100,000 | $237.65 | $23765K |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2013-04-12 | SELL | 3,129 | $211.01 | $660.3K |
| GOLDSTEIN JOSEPH L | Director | 2013-04-01 | SELL | 5,000 | $180 | $900K |
| BROWN MICHAEL S | Director | 2013-03-21 | SELL | 15,000 | $173.27 | $2599.1K |
| SCHLEIFER LEONARD S | President & CEO | 2013-03-19 | SELL | 3,655 | $175.02 | $639.7K |
| SCHLEIFER LEONARD S | President & CEO | 2013-03-13 | SELL | 4,662 | $175.01 | $815.9K |
| SCHLEIFER LEONARD S | President & CEO | 2013-03-07 | SELL | 91,683 | $175.33 | $16074.8K |
| SHOOTER ERIC M | Director | 2013-02-26 | SELL | 10,000 | $160 | $1600K |
| GOLDBERG MURRAY A | SVP Finance and Admin CFO Trea | 2013-01-16 | SELL | 7,878 | $172.16 | $1356.3K |
| GOLDSTEIN JOSEPH L | Director | 2013-01-09 | SELL | 5,000 | $185 | $925K |
| GOLDSTEIN JOSEPH L | Director | 2013-01-04 | SELL | 5,000 | $180.83 | $904.2K |
| Powchik Peter | SVP Clin Devel & Reg Affairs | 2013-01-03 | SELL | 13,586 | $182.11 | $2474.1K |
| Powchik Peter | SVP Clin Devel & Reg Affairs | 2012-12-20 | SELL | 16,979 | $175.43 | $2978.6K |
| McCorkle Douglas S | VP Controller & Asst Treasurer | 2012-12-19 | SELL | 2,593 | $176.47 | $457.6K |
| McCorkle Douglas S | VP Controller & Asst Treasurer | 2012-12-17 | SELL | 1,000 | $179.2 | $179.2K |
| Aberman Michael S | VP Strategy and Investor Relat | 2012-12-11 | SELL | 3,368 | $185.06 | $623.3K |
| Aberman Michael S | VP Strategy and Investor Relat | 2012-11-30 | SELL | 3,904 | $180.64 | $705.2K |
| STAHL NEIL | SVP Res and Devel Sciences | 2012-11-30 | SELL | 17,182 | $181.01 | $3110.1K |
| ROBERTS WILLIAM | VP Regulat Dev & Med Safety | 2012-11-30 | SELL | 11,500 | $180.78 | $2079K |
| VAGELOS P ROY | Chairman of the Board | 2012-11-29 | SELL | 85,634 | $179.1 | $15337K |
| SING GEORGE L | Director | 2012-11-29 | SELL | 5,000 | $185 | $925K |
| VAGELOS P ROY | Chairman of the Board | 2012-11-27 | SELL | 64,753 | $175.22 | $11346K |
| BAKER CHARLES A | Director | 2012-11-26 | SELL | 15,000 | $173.87 | $2608.1K |
| Terifay Robert J | SVP Commercial | 2012-11-23 | SELL | 9,745 | $174.45 | $1700K |
| STAHL NEIL | SVP Res and Devel Sciences | 2012-11-21 | SELL | 24,357 | $174.3 | $4245.4K |
| VAGELOS P ROY | Chairman of the Board | 2012-11-19 | SELL | 32,500 | $160.61 | $5219.8K |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2012-11-16 | SELL | 18,741 | $155.7 | $2918K |
| SING GEORGE L | Director | 2012-11-16 | SELL | 5,000 | $152 | $760K |
| GOLDBERG MURRAY A | SVP Finance and Admin CFO Trea | 2012-11-14 | SELL | 9,693 | $147.59 | $1430.6K |
| BROWN MICHAEL S | Director | 2012-11-14 | SELL | 7,000 | $147.03 | $1029.2K |
| SING GEORGE L | Director | 2012-11-13 | SELL | 5,000 | $148 | $740K |
| Powchik Peter | SVP Clinical Development & Reg | 2012-11-08 | SELL | 15,144 | $138.62 | $2099.3K |
| RYAN ARTHUR F | Director | 2012-11-01 | SELL | 10,000 | $145.57 | $1455.7K |
| BROWN MICHAEL S | Director | 2012-10-26 | SELL | 5,000 | $154.95 | $774.8K |
| Powchik Peter | SVP Clinical Development & Reg | 2012-09-19 | SELL | 7,177 | $147.17 | $1056.2K |
| BAKER CHARLES A | Director | 2012-09-06 | SELL | 15,000 | $150 | $2250K |
| GOLDBERG MURRAY A | SVP Finance and Admin CFO Trea | 2012-08-31 | SELL | 5,296 | $145.89 | $772.6K |
| STAHL NEIL | SVP Research and Development S | 2012-08-29 | SELL | 16,884 | $145.74 | $2460.7K |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2012-08-24 | SELL | 6,727 | $144.83 | $974.3K |
| ROBERTS WILLIAM | VP Regulatory Development and | 2012-08-23 | SELL | 15,000 | $144 | $2160K |
| SING GEORGE L | Director | 2012-08-23 | SELL | 10,000 | $140.5 | $1405K |
| RYAN ARTHUR F | Director | 2012-08-10 | SELL | 10,000 | $136.15 | $1361.5K |
| GILMAN ALFRED G | Director | 2012-08-07 | SELL | 15,000 | $139.56 | $2093.4K |
| BROWN MICHAEL S | Director | 2012-08-06 | SELL | 3,000 | $136.29 | $408.9K |
| Terifay Robert J | SVP Commercial | 2012-07-30 | SELL | 23,834 | $135.91 | $3239.3K |
| SING GEORGE L | Director | 2012-07-26 | SELL | 5,000 | $135 | $675K |
| Powchik Peter | SVP Clinical Development & Reg | 2012-07-26 | SELL | 7,019 | $130.64 | $917K |
| STAHL NEIL | SVP Res & Dev Sciences | 2012-06-19 | SELL | 38,911 | $116.02 | $4514.5K |
| SING GEORGE L | Director | 2012-05-31 | SELL | 10,000 | $134.44 | $1344.4K |
| SHOOTER ERIC M | Director | 2012-05-21 | SELL | 20,000 | $123.73 | $2474.6K |
| GOLDBERG MURRAY A | SVP Finance and Admin CFO Trea | 2012-05-03 | SELL | 31,587 | $135.4 | $4276.9K |
| YANCOPOULOS GEORGE | EVP CSO President Regeneron Re | 2012-05-01 | SELL | 33,165 | $134.83 | $4471.6K |
| Aberman Michael S | VP Strategy and Investor Relat | 2012-05-01 | SELL | 6,162 | $134.81 | $830.7K |
| SCHLEIFER LEONARD S | President & CEO | 2012-05-01 | SELL | 100,000 | $134.83 | $13483K |
| Van Plew Daniel P | SVP & General Mgr Industrial O | 2012-04-30 | SELL | 14,442 | $136.38 | $1969.6K |
| BAKER CHARLES A | Director | 2012-04-19 | SELL | 15,000 | $125 | $1875K |
| GOLDSTEIN JOSEPH L | Director | 2012-03-26 | SELL | 5,000 | $120 | $600K |
| YANCOPOULOS GEORGE | EVP CSO President Regeneron Re | 2012-03-26 | SELL | 33,150 | $120.24 | $3986K |
| GOLDSTEIN JOSEPH L | Director | 2012-03-15 | SELL | 10,000 | $112.9 | $1129K |
| BROWN MICHAEL S | Director | 2012-03-01 | SELL | 20,000 | $103.26 | $2065.2K |
| SHOOTER ERIC M | Director | 2012-02-23 | SELL | 20,000 | $103.53 | $2070.6K |
| Powchik Peter | SVP Clinical Development & Reg | 2012-02-22 | SELL | 49,254 | $96.34 | $4745.1K |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2012-02-16 | SELL | 19,012 | $109.61 | $2083.9K |
| GILMAN ALFRED G | Director | 2012-02-15 | SELL | 26,734 | $109.56 | $2929K |
| STAHL NEIL | SVP Research and Development S | 2012-02-15 | SELL | 52,284 | $109.21 | $5709.9K |
| GOLDSTEIN JOSEPH L | Director | 2012-02-14 | SELL | 15,000 | $110.02 | $1650.3K |
| GOLDBERG MURRAY A | SVP Finance and Admin CFO Trea | 2012-02-07 | SELL | 17,500 | $99.88 | $1747.9K |
| Terifay Robert J | SVP Commercial | 2012-02-01 | SELL | 9,439 | $90.59 | $855.1K |
| GOLDBERG MURRAY A | SVP Finance and Admin CFO Trea | 2012-02-01 | SELL | 18,258 | $91.76 | $1675.4K |
| GOLDBERG MURRAY A | SVP Finance and Admin CFO Trea | 2012-01-20 | SELL | 17,183 | $77.96 | $1339.6K |
| GOLDSTEIN JOSEPH L | Director | 2012-01-19 | SELL | 10,000 | $80 | $800K |
| RYAN ARTHUR F | Director | 2012-01-12 | SELL | 25,500 | $79.01 | $2014.8K |
| Terifay Robert J | SVP Commercial | 2012-01-11 | SELL | 9,019 | $74.2 | $669.2K |
| ROBERTS WILLIAM | VP Regulatory Development and | 2012-01-11 | SELL | 31,676 | $75.46 | $2390.3K |
| GOLDSTEIN JOSEPH L | Director | 2012-01-10 | SELL | 20,000 | $74.68 | $1493.6K |
| YANCOPOULOS GEORGE | EVP, CSO & Pres, REGN Res Labs | 2012-01-05 | SELL | 27,713 | $58 | $1607.4K |
| YANCOPOULOS GEORGE | EVP CSO President Regeneron Re | 2011-12-01 | SELL | 27,713 | $59.38 | $1645.6K |
| GOLDSTEIN JOSEPH L | Director | 2011-10-14 | SELL | 10,000 | $65 | $650K |
| Terifay Robert J | SVP Commercial | 2011-10-11 | SELL | 7,214 | $65.32 | $471.2K |
| BROWN MICHAEL S | Director | 2011-09-21 | SELL | 5,000 | $78 | $390K |
| GOLDBERG MURRAY A | SVP Finance and Admin CFO Trea | 2011-09-21 | SELL | 4,200 | $67 | $281.4K |
| GOLDBERG MURRAY A | SVP Finance and Admin CFO Trea | 2011-09-09 | SELL | 7,542 | $67.81 | $511.4K |
| BROWN MICHAEL S | Director | 2011-09-08 | SELL | 10,000 | $71.5 | $715K |
| Aberman Michael S | VP Strategy and Investor Relat | 2011-09-07 | SELL | 7,543 | $66.54 | $501.9K |
| ROBERTS WILLIAM | VP Regulatory Development and | 2011-09-07 | SELL | 22,966 | $67.32 | $1546.1K |
| STAHL NEIL | SVP Research and Development S | 2011-09-07 | SELL | 33,760 | $69.74 | $2354.4K |
| GOLDBERG MURRAY A | SVP Finance and Admin CFO Trea | 2011-09-07 | SELL | 13,531 | $69.73 | $943.5K |
| SCHLEIFER LEONARD S | CEO & President | 2011-09-06 | SELL | 7,900 | $66.03 | $521.6K |
| VAGELOS P ROY | Chairman of the Board | 2011-09-02 | SELL | 92,455 | $61.11 | $5649.9K |
| GOLDBERG MURRAY A | SVP Finance and Admin CFO Trea | 2011-08-16 | SELL | 6,409 | $56.85 | $364.4K |
| GOLDBERG MURRAY A | SVP Finance and Admin CFO Trea | 2011-07-28 | SELL | 9,705 | $54.75 | $531.3K |
| Powchik Peter | SVP Clinical Development | 2011-07-26 | SELL | 10,977 | $54.89 | $602.5K |
| ROBERTS WILLIAM | VP Regulatory Development and | 2011-07-14 | SELL | 110 | $56.7 | $6.2K |
| VAGELOS P ROY | Chairman of the Board | 2011-07-14 | SELL | 658 | $56.71 | $37.3K |
| VAGELOS P ROY | Chairman of the Board | 2011-07-13 | SELL | 74,342 | $57.41 | $4268K |
| ROBERTS WILLIAM | VP Regulatory Development and | 2011-07-13 | SELL | 12,390 | $57.4 | $711.2K |
| GOLDSTEIN JOSEPH L | Director | 2011-07-01 | SELL | 10,000 | $56.36 | $563.6K |
| BROWN MICHAEL S | Director | 2011-07-01 | SELL | 25,000 | $56.28 | $1407K |
| BAKER CHARLES A | Director | 2011-07-01 | SELL | 11,000 | $57.13 | $628.4K |
| GOLDSTEIN JOSEPH L | Director | 2011-05-04 | SELL | 5,000 | $48.89 | $244.5K |
| GILMAN ALFRED G | Director | 2011-05-02 | SELL | 20,000 | $50.77 | $1015.4K |
| BROWN MICHAEL S | Director | 2011-04-18 | SELL | 5,000 | $49 | $245K |
| STAHL NEIL | SVP Res and Dev Sciences | 2011-04-05 | SELL | 34,115 | $46.1 | $1572.7K |
| BROWN MICHAEL S | Director | 2011-03-31 | SELL | 3,309 | $44.65 | $147.7K |
| STAHL NEIL | SVP Res and Dev Sciences | 2011-03-30 | SELL | 7,692 | $45 | $346.1K |
| GOLDSTEIN JOSEPH L | Director | 2011-03-21 | SELL | 11,505 | $40 | $460.2K |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2011-03-21 | SELL | 10,600 | $40.02 | $424.2K |
| GILMAN ALFRED G | Director | 2011-03-17 | SELL | 1,700 | $38.97 | $66.2K |
| BROWN MICHAEL S | Director | 2011-03-10 | SELL | 8,094 | $39.65 | $320.9K |
| SHOOTER ERIC M | Director | 2011-03-09 | SELL | 27,500 | $40 | $1100K |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2011-03-09 | SELL | 9,400 | $40 | $376K |
| Terifay Robert J | SVP Commercial | 2011-03-04 | SELL | 6,099 | $38 | $231.8K |
| GOLDBERG MURRAY A | SVP F&A, CFO, Treas & Asst Sec | 2011-02-18 | SELL | 4,569 | $37.18 | $169.9K |
| Terifay Robert J | SVP Commercial | 2011-02-17 | SELL | 48,901 | $38 | $1858.2K |
| Terifay Robert J | SVP Commercial | 2011-02-14 | SELL | 5,000 | $37.02 | $185.1K |
| GOLDBERG MURRAY A | SVP F&A, CFO, Treas & Asst Sec | 2011-02-14 | SELL | 5,885 | $37.32 | $219.6K |
| GOLDSTEIN JOSEPH L | Director | 2011-02-11 | SELL | 2,761 | $36.66 | $101.2K |
| GOLDSTEIN JOSEPH L | Director | 2011-01-27 | SELL | 5,401 | $34.67 | $187.3K |
| ROBERTS WILLIAM | VP Regul Devel & Med Safety | 2011-01-26 | SELL | 2,693 | $34.49 | $92.9K |
| ROBERTS WILLIAM | VP Regul Devel & Med Safety | 2011-01-19 | SELL | 17,194 | $34.69 | $596.5K |
| BROWN MICHAEL S | Director | 2011-01-19 | SELL | 5,155 | $35.59 | $183.5K |
| SHOOTER ERIC M | Director | 2011-01-18 | SELL | 15,000 | $35 | $525K |
| Van Plew Daniel P | SVP & GM, Indust Ops&Prod Supp | 2011-01-18 | SELL | 25,000 | $35.22 | $880.5K |
| GOLDBERG MURRAY A | SVP F&A, CFO, Treas & Asst Sec | 2011-01-07 | SELL | 7,373 | $34.09 | $251.3K |
| VAGELOS P ROY | Director | 2011-01-06 | SELL | 21,043 | $34.04 | $716.3K |
| VAGELOS P ROY | Director | 2011-01-03 | SELL | 8,957 | $34.04 | $304.9K |
| BROWN MICHAEL S | Director | 2010-12-20 | SELL | 2,103 | $33.22 | $69.9K |
| GOLDSTEIN JOSEPH L | Director | 2010-12-17 | SELL | 5,281 | $32 | $169K |
| VAGELOS P ROY | Director | 2010-12-17 | SELL | 30,000 | $32.05 | $961.5K |
| GOLDBERG MURRAY A | SVP F&A, CFO, Treas & Asst Sec | 2010-12-17 | SELL | 5,168 | $32.15 | $166.2K |
| GOLDBERG MURRAY A | SVP F&A, CFO, Treas & Asst Sec | 2010-12-17 | SELL | 5,168 | $32.15 | $166.2K |
| Van Plew Daniel P | SVP & GM, Indust Ops&Prod Supp | 2010-12-16 | SELL | 25,000 | $32 | $800K |
| GOLDSTEIN JOSEPH L | Director | 2010-11-24 | SELL | 4,331 | $30.06 | $130.2K |
| VAGELOS P ROY | Director | 2010-11-23 | SELL | 30,000 | $30.03 | $900.9K |
| SHOOTER ERIC M | Director | 2010-11-23 | SELL | 7,500 | $30 | $225K |
| SANOFI-AVENTIS | 10% Owner | 2010-10-13 | BUY | 1,017,401 | $28 | $28487.2K |
| BROWN MICHAEL S | Director | 2010-10-07 | SELL | 1,765 | $28.03 | $49.5K |
| RYAN ARTHUR F | Director | 2010-06-14 | BUY | 10,000 | $26.98 | $269.8K |
| GOLDBERG MURRAY A | SVP F&A, CFO, Treas & Asst Sec | 2010-06-04 | SELL | 6,100 | $28.88 | $176.2K |
| BROWN MICHAEL S | Director | 2010-05-19 | SELL | 524 | $27.73 | $14.5K |
| SING GEORGE L | Director | 2010-05-18 | BUY | 7,500 | $28.51 | $213.8K |
| GOLDSTEIN JOSEPH L | Director | 2010-05-17 | SELL | 400 | $28.06 | $11.2K |
| VAGELOS P ROY | Director | 2010-05-14 | SELL | 20,000 | $27.16 | $543.2K |
| SHOOTER ERIC M | Director | 2010-02-17 | SELL | 15,000 | $30 | $450K |
| GOLDBERG MURRAY A | SVP F&A, CFO, Treas & Asst Sec | 2010-02-04 | SELL | 6,105 | $27.09 | $165.4K |
| ROBERTS WILLIAM | VP Regul Devel & Med Safety | 2010-02-04 | SELL | 7,843 | $27.55 | $216.1K |
| KOLINSKI STUART | SVP General Counsel and Secret | 2010-02-03 | SELL | 5,401 | $27.69 | $149.6K |
| McCorkle Douglas S | VP Controller and Asst Treasur | 2010-02-02 | SELL | 5,875 | $28 | $164.5K |
| ROBERTS WILLIAM | VP Regul Devel & Med Safety | 2010-01-28 | SELL | 2,119 | $26.56 | $56.3K |
| KOLINSKI STUART | SVP General Counsel and Secret | 2010-01-27 | SELL | 4,359 | $27 | $117.7K |
| SHOOTER ERIC M | Director | 2010-01-21 | SELL | 15,000 | $26 | $390K |
| GOLDBERG MURRAY A | SVP F&A, CFO, Treas & Asst Sec | 2010-01-06 | SELL | 12,708 | $24.88 | $316.2K |
| SHOOTER ERIC M | Director | 2010-01-05 | SELL | 15,000 | $25 | $375K |
| ROBERTS WILLIAM | VP Regul Devel & Med Safety | 2009-12-28 | SELL | 12,500 | $23.99 | $299.9K |
| SING GEORGE L | Director | 2009-11-13 | BUY | 12,500 | $18.76 | $234.5K |
| SCHLEIFER LEONARD S | Chief Exec Officer & President, 10% Owner | 2009-09-13 | SELL | 30,000 | $16.52 | $495.6K |
| ROBERTS WILLIAM | VP Regul Devel & Med Safety | 2009-09-01 | SELL | 14,166 | $23.49 | $332.8K |
| ROBERTS WILLIAM | VP Regul Devel & Clin Safety | 2009-08-12 | SELL | 6,666 | $22.99 | $153.3K |
| STAHL NEIL | SVP Res and Dev Sciences | 2009-07-27 | SELL | 37,423 | $20.55 | $769K |
| ROBERTS WILLIAM | VP Regul Devel & Clin Safety | 2009-04-27 | SELL | 15,160 | $12.74 | $193.1K |
| BAKER CHARLES A | Director | 2009-02-20 | SELL | 10,000 | $18.16 | $181.6K |
| YANCOPOULOS GEORGE | EVP, CSO, & Pres Regn Res Labs, Director | 2008-12-16 | SELL | 26,991 | $16.4 | $442.7K |
| GOLDSTEIN JOSEPH L | Director | 2008-10-01 | SELL | 500 | $22.32 | $11.2K |
| McCorkle Douglas S | VP, Controller and Asst. Treas | 2008-10-01 | SELL | 6,341 | $22.01 | $139.6K |
| McCorkle Douglas S | VP, Controller and Asst. Treas | 2008-10-01 | SELL | 4,957 | $21.3 | $105.6K |
| McCorkle Douglas S | VP, Controller and Asst. Treas | 2008-10-01 | SELL | 5,034 | $21.74 | $109.4K |
| STAHL NEIL | SVP, Research & Devel Sciences | 2008-09-30 | SELL | 10,317 | $21.63 | $223.2K |
| ROBERTS WILLIAM | VP, Regul Devel & Med Safety | 2008-09-22 | SELL | 9,692 | $22.84 | $221.4K |
| KOLINSKI STUART | SVP, Gen Counsel & Secretary | 2008-09-19 | SELL | 9,992 | $23.44 | $234.2K |
| SHOOTER ERIC M | Director | 2008-05-30 | SELL | 15,000 | $19.81 | $297.2K |
| BAKER CHARLES A | Director | 2008-02-15 | SELL | 10,000 | $18.84 | $188.4K |
| BAKER CHARLES A | Director | 2008-02-15 | SELL | 10,000 | $18.84 | $188.4K |
| BROWN MICHAEL S | Director | 2008-01-22 | SELL | 10,000 | $25 | $250K |
| GOLDSTEIN JOSEPH L | Director | 2008-01-22 | SELL | 5,000 | $25 | $125K |
| McCorkle Douglas S | VP, Controller and Asst. Treas | 2007-11-02 | SELL | 6,209 | $21 | $130.4K |
| SHOOTER ERIC M | Director | 2007-10-02 | SELL | 10,000 | $18.32 | $183.2K |
| GOLDBERG MURRAY A | SVP Fin & Admin, CFO, & Treas | 2007-04-26 | SELL | 8,931 | $27.08 | $241.9K |
| GOLDBERG MURRAY A | SVP Fin & Admin, CFO, & Treas | 2007-04-23 | SELL | 4,835 | $25.61 | $123.8K |
| STAHL NEIL | SVP, Research & Devel Sciences | 2007-04-23 | SELL | 10,988 | $25.61 | $281.4K |
| YANCOPOULOS GEORGE | EVP, CSO, & Pres Regn Res Labs | 2007-04-16 | SELL | 400 | $24.98 | $10K |
| YANCOPOULOS GEORGE | EVP, CSO, & Pres Regn Res Labs | 2007-04-16 | SELL | 30,883 | $24.54 | $757.9K |
| RUPP RANDALL | SVP, Manufuring Operations | 2007-04-13 | SELL | 31,250 | $24.99 | $780.9K |
| GOLDBERG MURRAY A | SVP Fin & Admin, CFO, & Treas | 2007-04-13 | SELL | 7,624 | $24.84 | $189.4K |
| YANCOPOULOS GEORGE | EVP, CSO, & Pres Regn Res Labs | 2007-04-09 | SELL | 9,556 | $23.82 | $227.6K |
| GILMAN ALFRED G | Director | 2007-02-26 | SELL | 1,400 | $21.55 | $30.2K |
| GILMAN ALFRED G | Director | 2007-02-26 | SELL | 8,600 | $21.46 | $184.6K |
| BAKER CHARLES A | Director | 2007-02-16 | SELL | 1,620 | $22.01 | $35.7K |
| BAKER CHARLES A | Director | 2007-02-16 | SELL | 8,380 | $21.86 | $183.2K |
| YANCOPOULOS GEORGE | EVP, CSO, & Pres Regn Res Labs | 2007-01-04 | SELL | 23,005 | $20.02 | $460.6K |
| SHOOTER ERIC M | Director | 2006-11-21 | SELL | 10,000 | $22.83 | $228.3K |
| GOLDBERG MURRAY A | SVP Fin & Admin, CFO, & Treas | 2006-11-20 | SELL | 1,200 | $24.76 | $29.7K |
| GOLDBERG MURRAY A | SVP Fin & Admin, CFO, & Treas | 2006-11-08 | SELL | 2,765 | $23.67 | $65.4K |
| GOLDBERG MURRAY A | SVP Fin & Admin, CFO, & Treas | 2006-11-08 | SELL | 20,097 | $23 | $462.2K |
| SCHLEIFER LEONARD S | Chief Exec Officer & President | 2006-11-07 | SELL | 53,986 | $23.12 | $1248.2K |
| BROWN MICHAEL S | Director | 2006-11-06 | SELL | 5,000 | $23 | $115K |
| STAHL NEIL | SVP, Therap & Clin Prog Dev | 2006-11-01 | SELL | 47,449 | $20.02 | $949.9K |
| RUPP RANDALL | SVP, Manufuring Operations | 2006-10-31 | SELL | 143,750 | $20.05 | $2882.2K |
| BROWN MICHAEL S | Director | 2006-10-31 | SELL | 4,000 | $20 | $80K |
| BROWN MICHAEL S | Director | 2006-10-19 | SELL | 4,469 | $18.67 | $83.4K |
| SCHLEIFER LEONARD S | Chief Exec Officer & President | 2006-10-17 | SELL | 30,000 | $18 | $540K |
| RUPP RANDALL | SVP, Manufuring Operations | 2006-09-01 | SELL | 23,461 | $15.71 | $368.6K |
| KOLINSKI STUART | VP, Gen Counsel & Secretary | 2006-08-17 | SELL | 2,000 | $15 | $30K |
| BROWN MICHAEL S | Director | 2006-03-16 | SELL | 3,258 | $17 | $55.4K |
| SHOOTER ERIC M | Director | 2006-03-10 | SELL | 5,283 | $17 | $89.8K |
| SCHLEIFER LEONARD S | Chief Exec Officer & President, 10% Owner | 2006-03-07 | SELL | 1,101 | $18 | $19.8K |
| STAHL NEIL | SVP, PreclinDevel & Biomol Sci | 2006-02-06 | SELL | 24,599 | $15.92 | $391.6K |
| BAKER CHARLES A | Director | 2006-02-01 | SELL | 10,000 | $15.34 | $153.4K |
| YANCOPOULOS GEORGE | EVP, CSO, & Pres Regn Res Labs | 2006-01-09 | SELL | 900 | $17.33 | $15.6K |
| STAHL NEIL | SVP, PreclinDevel & Biomol Sci | 2006-01-09 | SELL | 1,744 | $17.33 | $30.2K |
| GOLDBERG MURRAY A | SVP Fin & Admin, CFO, & Treas | 2006-01-09 | SELL | 2,177 | $17.33 | $37.7K |
| KOLINSKI STUART | VP, Gen Counsel & Secretary | 2006-01-09 | SELL | 1,621 | $17.33 | $28.1K |
| RUPP RANDALL | SVP, Manufuring Operations | 2006-01-09 | SELL | 5,682 | $16.12 | $91.6K |
| GILMAN ALFRED G | Director | 2006-01-06 | SELL | 900 | $16.46 | $14.8K |
| GILMAN ALFRED G | Director | 2006-01-06 | SELL | 9,100 | $16.18 | $147.2K |
| SHOOTER ERIC M | Director | 2006-01-04 | SELL | 2,406 | $15.89 | $38.2K |
| KOLINSKI STUART | VP, Gen Counsel & Secretary | 2005-12-27 | SELL | 3,000 | $15 | $45K |
| YANCOPOULOS GEORGE | EVP, CSO, & Pres Regn Res Labs | 2005-12-27 | SELL | 5,500 | $14.88 | $81.8K |
| GOLDBERG MURRAY A | SVP Fin & Admin, CFO, & Treas | 2005-12-27 | SELL | 12,642 | $13.16 | $166.4K |
| NOVARTIS PHARMA AG | 10% Owner | 2005-11-08 | SELL | 7,527,050 | $11.06 | $83249.2K |
| STAHL NEIL | SVP, PreclinDevel & Biomol Sci | 2005-08-05 | SELL | 10,677 | $9.47 | $101.1K |
| GOLDBERG MURRAY A | SVP Fin & Admin, CFO, & Treas | 2005-07-20 | SELL | 2,177 | $10 | $21.8K |
| KOLINSKI STUART | VP, Gen Counsel & Secretary | 2005-07-11 | SELL | 1,621 | $9.49 | $15.4K |
| GILMAN ALFRED G | Director | 2005-02-28 | SELL | 21,354 | $6.29 | $134.3K |
| BAKER CHARLES A | Director | 2005-02-22 | SELL | 10,000 | $6.52 | $65.2K |
| GOLDSTEIN JOSEPH L | Director | 2005-02-14 | SELL | 5,000 | $7.02 | $35.1K |
| BROWN MICHAEL S | Director | 2005-02-11 | SELL | 43,000 | $7.01 | $301.4K |
| GOLDSTEIN JOSEPH L | Director | 2005-02-07 | SELL | 15,000 | $7.38 | $110.7K |
| GILMAN ALFRED G | Director | 2005-02-07 | SELL | 23,646 | $7.5 | $177.3K |
| GOLDSTEIN JOSEPH L | Director | 2005-01-31 | SELL | 15,000 | $7 | $105K |
| GOLDSTEIN JOSEPH L | Director | 2005-01-24 | SELL | 15,000 | $7.11 | $106.7K |
| GOLDSTEIN JOSEPH L | Director | 2005-01-18 | SELL | 15,000 | $7.67 | $115.1K |
| RUPP RANDALL | SVP, Manuf & Process Sciences | 2004-10-15 | SELL | 10,000 | $7.27 | $72.7K |
| RUPP RANDALL | SVP, Manuf & Process Sciences | 2004-10-14 | SELL | 10,000 | $7.33 | $73.3K |
| RUPP RANDALL | SVP, Manuf & Process Sciences | 2004-10-13 | SELL | 30,000 | $7.95 | $238.5K |
| GULER HANS PETER | VP Clinical Programs | 2004-10-08 | SELL | 31,000 | $7.95 | $246.5K |
| RUPP RANDALL | SVP, Manuf & Process Sciences | 2004-07-14 | SELL | 16,000 | $8.71 | $139.4K |
| KOLINSKI STUART | VP, Gen Counsel & Secretary | 2004-07-09 | SELL | 855 | $9.14 | $7.8K |
| GULER HANS PETER | VP Clinical Programs | 2004-05-05 | SELL | 22,000 | $13.5 | $297K |
| GOLDSTEIN JOSEPH L | Director | 2004-05-03 | SELL | 5,000 | $13.05 | $65.3K |
| BROWN MICHAEL S | Director | 2004-05-03 | SELL | 10,000 | $12.6 | $126K |
| SHOOTER ERIC M | Director | 2004-03-01 | SELL | 5,000 | $14.89 | $74.5K |
| BAKER CHARLES A | Director | 2004-02-02 | SELL | 5,000 | $14.8 | $74K |
| YANCOPOULOS GEORGE | EVP, CSO, & Pres Regn Res Labs | 2004-01-09 | SELL | 1,339 | $15.33 | $20.5K |
| KOLINSKI STUART | VP, Gen Counsel & Secretary | 2004-01-09 | SELL | 1,565 | $15.33 | $24K |
| STAHL NEIL | SVP, PreclinDevel & Biomol Sci | 2004-01-09 | SELL | 2,115 | $15.33 | $32.4K |
| GOLDBERG MURRAY A | SVP Fin & Admin, CFO, & Treas | 2004-01-09 | SELL | 2,188 | $15.33 | $33.5K |
| GOLDSTEIN JOSEPH L | Director | 2003-10-08 | SELL | 13,000 | $14.51 | $188.6K |
| YANCOPOULOS GEORGE | EVP, CSO, & Pres Regn Res Labs | 2003-09-18 | SELL | 26,211 | $20.75 | $543.9K |
| GOLDBERG MURRAY A | SVP Fin & Admin, CFO, & Treas | 2003-09-18 | SELL | 15,000 | $20.74 | $311.1K |
| YANCOPOULOS GEORGE | EVP, CSO, & Pres Regn Res Labs | 2003-09-17 | SELL | 300 | $20.7 | $6.2K |
| YANCOPOULOS GEORGE | EVP, CSO, & Pres Regn Res Labs | 2003-09-17 | SELL | 49,600 | $20.43 | $1013.3K |
| RUPP RANDALL | SVP, Manufacturing | 2003-09-15 | SELL | 3,573 | $20.4 | $72.9K |
| SHOOTER ERIC M | Director | 2003-09-11 | SELL | 6,300 | $20.9 | $131.7K |
| SHOOTER ERIC M | Director | 2003-09-11 | SELL | 19,008 | $21.19 | $402.8K |
| SHOOTER ERIC M | Director | 2003-09-11 | SELL | 19,692 | $21.25 | $418.5K |
| GILMAN ALFRED G | Director | 2003-09-11 | SELL | 60,000 | $21.49 | $1289.4K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked